Disrupted sleep can trigger the development of type 2 diabetes, new research presented at the Diabetes UK Professional Conference (DUKPC) 2023 has identified.
Professor Martin Rutter, Honorary Consultant Physician at the Manchester Royal Infirmary, disclosed that frequent insomnia symptoms have a ‘casual role’ in elevating HbA1c.
- Study identifies ‘perfect’ HbA1c range for reducing risk of reoccurring heart attacks and strokes
- HbA1c Units Converter: DCCT to IFCC
According to his research, if an effective insomnia intervention could be delivered in the UK to all adults aged 40 to 70 with the sleep condition, approximately 27,000 of those would be free from having type 2 diabetes.
In addition, insomnia can also trigger the development of coronary artery disease, the study has reported.
Speaking at DUKPC 2023, Professor Rutter said: “Sleep disturbance has a real role in diabetes. We have seen that short sleep is associated with an increased risk of myocardial infarction.”
Myocardial infarction is more commonly known as a heart attack and happens when the blood flow to a part of the heart is blocked leading to damage of the heart muscle.
Sleep apnoea is also a common condition in people living with diabetes, according to the research.
Professor Martin Rutter’s research was presented at the Diabetes UK Annual Conference which took place in Liverpool.
